Literature DB >> 9794474

Direct measurement of the contributions of type I and type II 5'-deiodinases to whole body steady state 3,5,3'-triiodothyronine production from thyroxine in the rat.

T T Nguyen1, F Chapa, J J DiStefano.   

Abstract

Production of T3 from T4 in tissues is catalyzed by two 5'-deiodinases, type I (D1) and type II (D2), but the quantitative contribution of each pathway to whole body T3 production is not well established. In the presence of propylthiouracil (PTU), D1, but not D2, can be effectively blocked, providing an experimental probe for addressing this problem. Decades ago, this approach provided indirect estimates ranging from 23-44% contribution by D2, based on plasma T3 appearance rate comparisons (PAR3 = PCR3 [T3]p) in periodically T4-injected athyreotic rats vs. controls. Two, more recent studies, using constant infusions of T4 for replacement, achieved 22% and 65% estimates, respectively, from PAR3 comparisons. We have revisited this problem more directly and precisely, with two major differences in experiment design. We used direct whole body steady state measurements of T3 production, instead of indirect plasma-only data (PAR3). We also used (euthyroid) physiological doses of both T4 (0.9 microg/day x 100 g BW) and T3 (0.15 microg/day x 100 g BW) for replacement in two thyroidectomized rat groups, instead of T4 only, in a 7-day constant steady state, dual tracer infusion protocol. The first group also had chronically implanted 150-mg PTU pellets (TXR-PTU); the other had implanted 0.1 N NaOH placebo pellets (TXR-EU); each delivered their product at constant rates. A third euthyroid intact group was used as the controls. The completeness of D1 inhibition was ascertained in a fourth group, identically treated with 150-mg PTU pellets, in which negligible D1 activity was found in liver and kidney using labeled rT3 as substrate for the 5'-D assays and minimal (1 mM) dithiothreitol as cofactor. In the TXR-PTU group, the percentage of T4 converted to T3 was 11.8%, compared with 23.4% (P < 0.0005) in the TXR-EU group, and 22.7% (P = NS) in controls. Thus, in euthyroid steady state, D2 contributes about half of the T3 produced from T4.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794474     DOI: 10.1210/endo.139.11.6323

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability.

Authors:  J Köhrle
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue.

Authors:  L A de Jesus; S D Carvalho; M O Ribeiro; M Schneider; S W Kim; J W Harney; P R Larsen; A C Bianco
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 3.  Thyroid hormone deiodinases revisited: insights from lungfish: a review.

Authors:  M Sutija; J M P Joss
Journal:  J Comp Physiol B       Date:  2005-09-08       Impact factor: 2.200

Review 4.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

5.  AlphaANP, AVP, and pituitary-thyroid axis in patients with congestive heart failure and acute respiratory failure.

Authors:  S Savastano; V Cannavale; R Valentino; A P Tommaselli; R Rossi; A Luciano; L Tauchmanovà; A Mariano; L Mazzitelli; V Macchia; G Lombardi
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

6.  Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism.

Authors:  Alessandro Marsili; Waile Ramadan; John W Harney; Michelle Mulcahey; Luciana Audi Castroneves; Iuri Martin Goemann; Simone Magagnin Wajner; Stephen A Huang; Ann Marie Zavacki; Ana Luiza Maia; Monica Dentice; Domenico Salvatore; J Enrique Silva; P Reed Larsen
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

7.  Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

Authors:  J Pachucki; M Ambroziak; Z Tanski; J Luczak; J Nauman; A Nauman
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

8.  Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver.

Authors:  Lars P Klieverik; Sarah F Janssen; Annelieke van Riel; Ewout Foppen; Peter H Bisschop; Mireille J Serlie; Anita Boelen; Mariëtte T Ackermans; Hans P Sauerwein; Eric Fliers; Andries Kalsbeek
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

9.  Life without the iodothyronine deiodinases.

Authors:  Valerie Anne Galton; Ellis de Waard; Albert F Parlow; Donald L St Germain; Arturo Hernandez
Journal:  Endocrinology       Date:  2014-06-20       Impact factor: 4.736

10.  Prolonged food deprivation increases mRNA expression of deiodinase 1 and 2, and thyroid hormone receptor β-1 in a fasting-adapted mammal.

Authors:  Bridget Martinez; José G Soñanez-Organis; José Pablo Vázquez-Medina; Jose A Viscarra; Duncan S MacKenzie; Daniel E Crocker; Rudy M Ortiz
Journal:  J Exp Biol       Date:  2013-12-15       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.